Calcifying nested stromal-epithelial tumor (CNSET) of the liver is an extremely rare primary tumor of nonhepatic and non-biliary origins which generally affects children and young adults, mainly women. We report a case of 28-year-old woman with a history of oral contraceptive consumption for 9 years, who underwent surgery for a large right hepatic mass that proved to be a CNSET, according to the pathology report. Postoperatively the patient had a slow recovery and after discharge the patient was sent to the oncology department where she underwent several treatment cycles with Imatinib. The case report documented all the clinical and histopathological features necessary for diagnosis of CNSET. CNSET of liver should always be considered and included in the differential diagnosis of hepatic tumors especially if the patient is a young woman with a long history of oral contraceptive consumption and an abdominal palpable mass.
Introduction
Calcifying nested stromal-epithelial tumor (CNSET) of the liver is an extremely rare primary tumor of non-hepatic and non-biliary origins [1] consisting of nests of spindled and epithelioid cells that can associate calcification or bone formation [2] . As far as we know only 37 cases were previously described in the literature under different names like: 
Case report Preoperative assessment and surgical therapy
A 28-year-old Caucasian woman was admitted to Surgery Department of our hospital with upper abdominal pain, asthenia and fatigue. The patient had a history of oral contraceptive consumption for 9 years, but no history of hepatitis, alcohol use, and consumption of hepatotoxic medication or a family history of hepatic malignancy.
Physical examination revealed pallor, pain in the upper abdominal area and a large palpable mass in the right hypochondriac and lumbar region. No Cushingoid or other clinical symptoms were present. Laboratory tests revealed a low level of hemoglobin (9.4 g/dl) and hematocrit (29.9 %). Serum levels of gamma-glutamyl transferase, aspartate transaminase, alanine transaminase, alpha-fetoprotein, carbohydrate antigen 19-9 and carcinoembryonic antigen were normal. Serology results for hepatitis B and C were negative.
Abdominal ultrasound and computer tomography (CT) revealed a large nonhomogeneous mass with irregular borders, Doppler signal and small nodular calcifications that involved the right hepatic lobe entirely ( Figure 1 ). The CT images showed a mass confined to the liver that caused mass effect and compression to the adjacent structures. No biopsy was taken.
Based on the preoperative assessment the patient was scheduled for liver resection, with a presumptive diagnosis of hepatocellular carcinoma. Exploratory laparotomy was done followed by a right hepatectomy.
Fig. 1. Ultrasound shows a large nonhomogeneous mass with irregular borders (a) and Doppler signal present (b).

Pathology -gross appearance
The tumor had a non-encapsulated, still well-defined, lobulated feature. It appeared as a large mass of about 34/19/12 cm that occupied the entire right hepatic lobe. On cut surface, the tumor was solid, heterogeneous, with white areas and large cystic spaces ( Figure 2 ). Due to the unusual histological appearance, the immunohistochemical (IHC) tests were done in a stepwise fashion, in order to confirm and/or to exclude certain presumable entities.
Therefore, the panel of markers included CD117, DOG1 and CD34 for gastrointestinal stromal tumor (GIST), CK AE1/AE3, CK5, CK7, CK20, TTF-1 and p63 for carcinoma of digestive, pulmonary or squamous origin, Synaptophysin and Chromogranin A for neuroendocrine neoplasia, S100, Melan-A and HMB45 for malignant melanoma, HSA for hepatocellular carcinoma or hepatoblastoma, Vimentin and SMA for sarcoma and Ki-67 to evaluate the mitotic activity.
Tumor cells were positive for CK AE1/AE3, S100, focally positive for CD117 and Vimentin, while negative for the rest of the markers. Ki-67 showed positivity in less than 10% of tumor cells.
A rare and lesser known entity, CNSET, had to be proven using CD56, WT1 and EMA. Tumor cells were positive for CD56, focally positive for WT1 and negative for EMA, a pattern consistent with the diagnosis of CNSET (Figure 4 ).
Postoperative assessment
Postoperatively the patient had a slow recovery with a small fluid collection in right hypochondriac region, right lumbar region and hypogastrium that resolved in the following weeks. After discharge the patient was sent to oncology department to continue the treatment with several chemotherapy cycles of Imatinib.
Discussion
Calcifying nested stromal-epithelial tumor (CNSET) of the liver is an extremely rare tumor occurring mainly in females (76%) with nearly 70% of reported cases in children [5] . This rare entity typically displays nests of spindled and epithelioid cells that associate calcifications or bone formation, surrounded by moderate fibrovascular stoma [1] [2] [3] [4] [5] [6] [7] .
The small number of CNSETs reported in literature makes it challenging to properly evaluate the clinical behavior and outcome in patients with this type of tumors [1, 8] . So far, only three metastatic cases have been reported (lung, liver and lymph nodes) and a few cases had recurrences, features which confirm that CNSET could be considered a low-grade malignancy [3, 5, 9].
The pathogenesis of CNSET remains uncertain. A few cases had a Cushing syndrome that resolved after surgery [3, 8] . Three cases were reported in patients with Beckwith-Weideman syndrome [1] . Similar to our case, a few others had a history of oral contraceptive pills consumption but no direct association was proven [5] .
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Other theories suggest the implication of WT1, due to its role in the transformation of mesenchymal cells into epithelial cells [5] and of Beta-catenin and other mesenchymalepithelial transition factors like: SNAIL, SLUG, TWIST, c-Met, vimentin and E-cadherin. Apart from E-cadherin, all others have an increased expression in the CNSET tumor cells. This hypothesis needs further research and validation due to the small number of cases included in the study [10] . Surgery seems to be the gold standard for therapy. In regards to chemotherapy, there are no well-defined protocols that can be applied, which suggests an individualized approach to the course of treatment [7] .
Conclusion
CNSET of liver is a rare primary tumor of non-hepatic and non-biliary origins that is considered a low-grade malignancy. The diagnosis of CNSET should be established on morphology and IHC, especially when the patient is a young woman with an abdominal palpable mass, a history of oral contraceptive consumption and Cushingoid symptoms or a history of Beckwith-Weideman syndrome.
